Joshua Reed | CFO |
Todd Brady | CEO, President & Director |
Victor Rusu | Citigroup |
Esther Hong | Janney Montgomery Scott |
I-Eh Jen | Laidlaw & Company |
Matthew Cross | JonesTrading Institutional Services |
Good morning. My name is Carol, and I will be your operator today. At this time, I would like to welcome everyone to the Aldeyra Therapeutics reports second quarter 2019 financial results call. [Operator Instructions]. At this time, I would like to turn the call over to Joshua Reed, Chief Financial Officer.